Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: Insights from the two-year outcome of the TWENTE trial

Hanim Sen, Ming Kai Lam, Kenneth Tandjung, Mounir W.Z. Basalus, Frits H.A.F. de Man, J. Hans W. Louwerenburg, Martin G. Stoel, Gert K. van Houwelingen, Marije M. Löwik, Gerard C.M. Linssen, Salah A.M. Saïd, Mark B. Nienhuis, Patrick M.J. Verhorst, Job van der Palen, Clemens von Birgelen

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)
72 Downloads (Pure)

Fingerprint Dive into the research topics of 'Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: Insights from the two-year outcome of the TWENTE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences